Fei‐Fei Luo

机构：Chinese University of Hong Kong, Fudan University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Huashan Hospital, Southern Medical University · ORCID：0000-0002-6543-0023

发表论文 22 篇 · 总被引 358 次 · h-index 10

代表论文

• Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation (2022 · Advanced Science · 被引 72)
• Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy (2023 · Frontiers in Immunology · 被引 62)
• S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1 (2020 · Oncogene · 被引 51)
• LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival (2020 · Cancer Letters · 被引 33)
• AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway (2020 · Journal of Cellular and Molecular Medicine · 被引 23)
• Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells (2020 · Biochemical and Biophysical Research Communications · 被引 23)